MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 26.36
+1.30 (5.19%)
Jun 23, 2026, 5:35 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €946.43 million as of June 23, 2026. Its market cap has increased by 85.24% in one year.
Market Cap
946.43M
Enterprise Value
966.52M
Revenue
32.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€26.36
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 946.43M, an increase of 547.77%. That is a compound annual growth rate of 27.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 946.43M | 13.45% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 6.84B |
| Nanobiotix | 1.54B |
| DBV Technologies | 838.03M |
| Inventiva | 624.16M |
| Genfit | 533.81M |
| Valneva SE | 437.14M |
| Transgene | 204.59M |
| Cellectis | 193.85M |